Clinical Trial Update: Gemcitabine and Sorafenib in Advanced Biliary Tract Cancer (GEMSO) [Phase 2]

View source ↗

Summary

Phase 2 trial update for the combination of gemcitabine and sorafenib in advanced biliary tract cancer (GEMSO) has completed and results were posted in 2013.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Biliary Tract Cancer
• Cholangiocarcinoma

Drugs mentioned

• Gemzar (gemcitabine)
• Nexavar (Sorafenib)

Snippet

Sponsor: PD Dr Markus Möhler | Conditions: Adenocarcinoma | Phase 2 | Status: COMPLETED | Results posted: 2013-11-21